Jennifer Robblee MD(@JenniferRobblee) 's Twitter Profileg
Jennifer Robblee MD

@JenniferRobblee

Headache neurologist @BarrowNeuro. Chronic migraine too. (views are my own) #NotJustAHeadache she/her

ID:1183083117000585216

linkhttps://www.barrowneuro.org/get-to-know-barrow/person/jennifer-robblee-md/ calendar_today12-10-2019 18:13:32

1,1K Tweets

1,2K Followers

414 Following

Follow People
Brad Racette, MD(@BradRacette) 's Twitter Profile Photo

A population-based, case-control study from my lab associated the gout medication allopurinol with a lower risk of , , & . Our findings were published yesterday in @PLOSOne. Learn more: bar.rw/allopurinol. Month

A population-based, case-control study from my lab associated the gout medication allopurinol with a lower risk of #Alzheimers, #Parkinsons, & #ALS. Our findings were published yesterday in @PLOSOne. Learn more: bar.rw/allopurinol. #ALSMonth
account_circle
BarrowNeurological(@BarrowNeuro) 's Twitter Profile Photo

A population-based, case-control study co-authored by Barrow Chairman & Senior VP Dr. Brad Racette, MD associated a common gout medication with a reduced risk of , , & . Press release: bar.rw/42GY4k6

Month AwarenessMonth

A population-based, case-control study co-authored by Barrow #Neurology Chairman & Senior VP Dr. @BradRacette associated a common gout medication with a reduced risk of #Alzheimers, #Parkinsons, & #ALS. Press release: bar.rw/42GY4k6 #ALSMonth #ALSAwarenessMonth
account_circle
American Headache Society(@ahsheadache) 's Twitter Profile Photo

The AHS and @NINDSnews are soliciting input from all interested stakeholders, including researchers, health care providers, individuals with disorders, patient advocates and health organizations, scientific or professional organizations, federal agencies, and…

The AHS and @NINDSnews are soliciting input from all interested stakeholders, including researchers, health care providers, individuals with #headache disorders, patient advocates and health #advocacy organizations, scientific or professional organizations, federal agencies, and…
account_circle
Migraine Science Collaborative(@MigraineCollab) 's Twitter Profile Photo

Help Shape the Future of Headache Research!

@NINDSnews and American Headache Society have partnered to develop priorities – and the broader headache community is now welcomed to provide feedback on this effort. Provide your input today!

🔗 ninds.ideascalegov.com/c/campaigns/12…

Help Shape the Future of Headache Research! @NINDSnews and @ahsheadache have partnered to develop #headache #research priorities – and the broader headache community is now welcomed to provide feedback on this effort. Provide your input today! 🔗 ninds.ideascalegov.com/c/campaigns/12…
account_circle
Brad Racette, MD(@BradRacette) 's Twitter Profile Photo

The Barrow Neuromuscular Disorders team, led by Shafeeq Ladha, played a key role in research trials that led to the approval of . The new drug targets a genetic form of and is a great example of personalized medicine for ALS.

barrowneuro.org/about/news-and…

account_circle
Jennifer Robblee MD(@JenniferRobblee) 's Twitter Profile Photo

Finish line is here. What a great week at 2023 in Boston! Thanks for all the learning, networking and inspiration. And my hat!

Finish line is here. What a great week at #AANAM 2023 in Boston! Thanks for all the learning, networking and inspiration. And my hat!
account_circle
Jennifer Robblee MD(@JenniferRobblee) 's Twitter Profile Photo

DHE via IV was viewed as a favorable treatment for status migrainosus, though it was underutilized and often only as a last resort due to accessibility issues.
 
INP104 allows patients to administer DHE at home with IV-like efficacy.
 
Abstract: aan.com/MSA/Public/Eve…

account_circle
Jennifer Robblee MD(@JenniferRobblee) 's Twitter Profile Photo

Check out my poster at today!
 
Status migrainosus is a debilitating complication with intense symptoms lasting over 72h. Our survey entailed phone interviews with 33 headache specialists from across the U.S.

Check out my poster at #AANAM today!   Status migrainosus is a debilitating #migraine complication with intense symptoms lasting over 72h. Our survey entailed phone interviews with 33 headache specialists from across the U.S.
account_circle
Jennifer Robblee MD(@JenniferRobblee) 's Twitter Profile Photo

Come learn how headache neurologists currently approach status migrainosus and participate in the survey yourself! Happening soon in neighborhood 12! Come visit me to chat!
BarrowNeurological

Come learn how headache neurologists currently approach status migrainosus and participate in the survey yourself! Happening soon in neighborhood 12! Come visit me to chat! #AANAM @BarrowNeuro
account_circle
BarrowNeurological(@BarrowNeuro) 's Twitter Profile Photo

: We're offering a free, self-paced Bootcamp! The virtual course is available online through 2026 & covers various neurological conditions, neuroanatomy, & more. Get started here: bar.rw/appbootcamp

#ICYMI: We're offering a free, self-paced #AdvancedPracticeProvider #Neurology Bootcamp! The virtual course is available online through 2026 & covers various neurological conditions, neuroanatomy, & more. Get started here: bar.rw/appbootcamp
account_circle
Jennifer Robblee MD(@JenniferRobblee) 's Twitter Profile Photo

It really was catching up with old friends (but yes finally in-person) while also making so new!! Women Neurologists Group is such a special group of the most inspiring women❤️

account_circle